<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested the hypothesis that <z:hpo ids='HP_0001824'>weight loss</z:hpo> alleviates <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in skeletal muscle within the proximal steps of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, namely substrate delivery, <z:chebi fb="105" ids="17234">glucose</z:chebi> transport, and <z:chebi fb="105" ids="17234">glucose</z:chebi> phosphorylation </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:mp ids='MP_0001261'>obese</z:mp> subjects with and without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, in vivo skeletal muscle assessments were obtained with dynamic <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography (PET) imaging performed during euglycemic clamps at moderate <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo> (40 mU x min(-1) x m(-2)), using [(15)O]<z:chebi fb="0" ids="15377">H(2)O</z:chebi> and [(18)F]fluoro-<z:chebi fb="0" ids="15866">deoxyglucose</z:chebi> ([(18)F]FDG) to quantify tissue perfusion and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>Dynamic [(18)F]FDG PET data were analyzed using both a novel muscle-specific compartmental model and a compartmental model originally developed for the brain and often used for [(18)F]FDG muscle image quantification </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001824'>Weight loss</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> subjects with (n = 9) and without (n = 9) type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> over a 4-month intervention was substantial (14 +/- 2 kg, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Muscle <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, assessed by insulin-stimulated [(18)F]FDG uptake, decreased threefold in diabetic subjects and twofold in nondiabetic subjects (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Kinetic parameters for [(18)F]FDG transport and phosphorylation improved substantially in both groups, whereas tissue blood flow did not change </plain></SENT>
<SENT sid="6" pm="."><plain>In particular, clinically significant <z:hpo ids='HP_0001824'>weight loss</z:hpo> fully corrected <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> at the step of <z:chebi fb="105" ids="17234">glucose</z:chebi> phosphorylation and largely, but incompletely, corrected <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> at the <z:chebi fb="105" ids="17234">glucose</z:chebi> transport step </plain></SENT>
</text></document>